Group of Medical Biotechnology

Team leader
Assoc. Prof. Anna Lewińska, alewinska@ur.edu.pl, ORCID 0000-0001-8055-1918

Anna Lewińska received a PhD in biological sciences from the University of Rzeszow, Poland in 2011 (the title of PhD thesis: „The role of flavohemoglobin in the protection against reactive nitrogen species and reactive oxygen species in the yeast Saccharomyces cerevisiae”) and a DSc in biological sciences (habilitation; discipline, biotechnology; specialization, molecular biotechnology, the tile of main achievement: “Molecular mechanisms underlying cancer cell responses to plant-derived nutraceuticals – the evaluation of potential applications in anticancer therapy”) from the Maria Curie-Sklodowska University in Lublin, Poland in 2018. She is currently an associate professor in the Faculty of Biotechnology, Collegium Medicum, University of Rzeszow, Poland. She was awarded START scholarship for young, talented researchers at the outset of their career (The Foundation for Polish Science, discipline biochemistry, 2010). She is serving as an editor or guest editor in several scientific journals (e.g., BBA Reviews on Cancer, Heliyon, Frontiers in Genetics, Frontiers in Oncology). Her general scientific interests are cancer biology, cellular senescence, nanotoxicology, and nano-systems for drug delivery, nutraceuticals, stress responses, and epigenetics.
Members of research group

Paulina Stec, Julia Słaby, Anna Lewińska, Anna Deręgowska